• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Determination of N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4 -acridinecarboxamide in plasma by high-performance liquid chromatography.

作者信息

Jurlina J L, Paxton J W

出版信息

J Chromatogr. 1985 Aug 9;342(2):431-5. doi: 10.1016/s0378-4347(00)84539-9.

DOI:10.1016/s0378-4347(00)84539-9
PMID:3840491
Abstract
摘要

相似文献

1
Determination of N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenylamino]-4 -acridinecarboxamide in plasma by high-performance liquid chromatography.采用高效液相色谱法测定血浆中N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺的含量。
J Chromatogr. 1985 Aug 9;342(2):431-5. doi: 10.1016/s0378-4347(00)84539-9.
2
Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.氨吖啶新衍生物N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯氨基]-4-吖啶甲酰胺的合成、抗肿瘤活性及DNA结合特性
Cancer Res. 1984 Aug;44(8):3245-51.
3
The effect of food on the bioavailability and kinetics of the anticancer drug amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]-4 acridinecarboxamide in rabbits.食物对家兔体内抗癌药物安吖啶及其新类似物N-5-二甲基-9-[(2-甲氧基-4-甲磺酰氨基)苯氨基]-4-吖啶甲酰胺生物利用度和动力学的影响。
J Pharm Pharmacol. 1986 Nov;38(11):837-40. doi: 10.1111/j.2042-7158.1986.tb04505.x.
4
Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.抗癌药物安吖啶与一种新类似物N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺在兔体内的药代动力学及蛋白结合率比较
Cancer Chemother Pharmacol. 1986;16(3):253-6. doi: 10.1007/BF00293987.
5
Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in rabbits.
Cancer Chemother Pharmacol. 1987;20(1):13-5. doi: 10.1007/BF00252952.
6
The binding of amsacrine to human plasma proteins.安吖啶与人血浆蛋白的结合。
J Pharm Pharmacol. 1986 Jun;38(6):432-8. doi: 10.1111/j.2042-7158.1986.tb04606.x.
7
Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice.氨吖啶及其类似物9-([2-甲氧基-4-[(甲基磺酰基)氨基]苯基]氨基)-N,5-二甲基-4-吖啶甲酰胺（CI-921）在小鼠血浆、肝脏和Lewis肺癌中的分布。
Cancer Res. 1990 Feb 1;50(3):503-8.
8
Effects of a new amsacrine derivative, N-5-dimethyl-9-(2-methoxy-4-methylsulfonylamino)phenylamino-4- acridinecarboxamide, on cultured mammalian cells.
Cancer Res. 1987 Jan 15;47(2):424-32.
9
Development and validation of bioanalytical method for the determination of asulacrine in plasma by liquid chromatography.液相色谱法测定血浆中阿苏克林的生物分析方法的建立与验证
J Pharm Biomed Anal. 2008 Jan 22;46(2):386-90. doi: 10.1016/j.jpba.2007.09.025. Epub 2007 Oct 2.
10
The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in the rabbit.
Cancer Chemother Pharmacol. 1989;23(5):291-5. doi: 10.1007/BF00292406.

引用本文的文献

1
Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.抗癌药物安吖啶与一种新类似物N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺在兔体内的药代动力学及蛋白结合率比较
Cancer Chemother Pharmacol. 1986;16(3):253-6. doi: 10.1007/BF00293987.
2
Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in rabbits.
Cancer Chemother Pharmacol. 1987;20(1):13-5. doi: 10.1007/BF00252952.
3
The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4 -acridinecarboxamide (CI-921) in a phase 1 trial.N-5-二甲基-9-[(2-甲氧基-4-甲基磺酰氨基)苯基氨基]-4-吖啶甲酰胺（CI-921）在1期试验中的临床药代动力学
Cancer Chemother Pharmacol. 1988;22(3):235-40. doi: 10.1007/BF00273417.
4
The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in the rabbit.
Cancer Chemother Pharmacol. 1989;23(5):291-5. doi: 10.1007/BF00292406.